By Professor Susan Jane Connor

Journal articles

Barnett M; Su WK; Pipicella J; Kaur H; Wilson W; Connor SJ; Andrews JM, 2025, 'Comparing Real-World use of Dietary and Medical Therapies in Children and Adults with IBD', JOURNAL OF CROHNS & COLITIS, 19, pp. i1775 - i1775, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1124

Su WK; McNamara J; Wilson W; Wark G; Lynch K; Su H; Forbes A; Lawrance I; An YK; Dutt S; Brett L; Walker G; Andrews JM; Connor SJ; Ghaly S, 2025, 'DOP015 Consistency and Quality of Inflammatory Bowel Disease care in Australasia; Towards Benchmarking, Crohn’s Colitis Cure Data Insight’s Program', Journal of Crohn's and Colitis, 19, pp. i111 - i112, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0054

Su WK; Wilson W; Ng W; Su H; Forbes A; Walker G; Kim A; Giles E; Lawrance I; Dutt S; Brett L; An YK; Lynch K; Connor SJ; Andrews JM, 2025, 'DOP106 Geographic disparities in Healthcare Utilisation in people with inflammatory bowel disease, Crohn’s Colitis Cure Data Insights Program', Journal of Crohn's and Colitis, 19, pp. i277 - i278, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0145

Davidson C; Su WK; Wilson W; Rivas C; Antoniades S; Wark G; Su H; Ghaly S; Grafton R; Andrews JM; Connor SJ, 2025, 'Factors associated with Inflammatory Bowel Disease (IBD) helpline (HL) utilisation: Crohn's Colitis Cure Data Insight's Program', JOURNAL OF CROHNS & COLITIS, 19, pp. i2481 - i2482, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1558

Cabaero AG; Su WK; Wilson W; Rivas C; Antoniades S; Ng W; Forbes A; Arnold K; Grafton R; Andrews JM; Connor SJ, 2025, 'Inflammatory bowel disease helpline use amongst individuals who are culturally and linguistically diverse, Crohn's Colitis Cure Data Insight's Programme', JOURNAL OF CROHNS & COLITIS, 19, pp. i2495 - i2496, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1568

Koentgen S; Cosier D; Tavakoli P; Leach ST; Dutt S; Ghaly S; Connor SJ; Lemberg DA; Lambert K; Hold GL, 2025, 'P0018 Fat rich dietary habits: Further increasing IBD risk in first degree relatives', Journal of Crohn's and Colitis, 19, pp. i358 - i358, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0192

Koentgen S; Zhang F; Wu N; Jayawardana T; Little R; Tavakoli P; Ghaly S; Connor SJ; Hold GL, 2025, 'P0203 Unique faecal & oral microbiota signatures in first degree relatives of inflammatory bowel disease patients', Journal of Crohn's and Colitis, 19, pp. i607 - i607, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0377

Pudipeddi A; Dhanji P; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An YK; Begun J; Connor S; Corte C; Ward M; De Cruz P; Fung C; Redmond D; Chan W; Mourad F; Kermeen M; Leong R, 2025, 'P0257 Correlation of biochemical, endoscopic and histologic endpoints in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial', Journal of Crohn's and Colitis, 19, pp. i689 - i690, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0431

Su WK; Wilson W; Wark G; Walker G; Su H; Forbes A; Kim A; Giles E; Lawrance I; Dutt S; Brett L; Begun J; Lynch K; Andrews JM; Connor SJ, 2025, 'P0341 Variation in healthcare utilisation amongst IBD care centres in Australia and New Zealand, Crohn’s Colitis Care Data Insight’s Program', Journal of Crohn's and Colitis, 19, pp. i808 - i809, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0515

Alsulaibi O; Su WK; Wilson W; Sin L; Ng W; Walker G; Forbes A; Lawrance I; Lynch K; Begun J; Connor SJ; Andrews JM, 2025, 'P0568 Mortality and comorbidities in people with Inflammatory Bowel Disease - Crohn’s Colitis Cure data insights program', Journal of Crohn's and Colitis, 19, pp. i1140 - i1141, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0742

Chan P; Su WK; Wilson W; Cabaero A; Antoniades S; Forbes A; Arnold K; Grafton R; Andrews J; Connor S, 2025, 'P0569 Inflammatory Bowel Disease nursing helpline trends in a large real-world Australasian cohort: Crohn's Colitis Cure (CCC) data insights program', Journal of Crohn's and Colitis, 19, pp. i1142 - i1143, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0743

Su WK; Wilson W; Wark G; Ghaly S; Lynch K; Lawrance I; Walker G; Forbes A; Brett L; An YK; Connor SJ; Andrews JM, 2025, 'P0603 The real-world use of intravenous and subcutaneous Vedolizumab in IBD across Australia and New Zealand, Crohn’s Colitis Cure Data Insight’s Program', Journal of Crohn's and Colitis, 19, pp. i1197 - i1198, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0777

Pinnuck B; Su WK; Wilson W; Pipicella J; Ng W; Antoniades S; Walker G; Forbes A; Dutt S; Lynch K; Connor SJ; Andrews JM, 2025, 'P0678 Iron deficiency, with or without anaemia, in Inflammatory Bowel Disease remains an undermanaged issue: Crohn’s Colitis Cure Data Insights Program', Journal of Crohn's and Colitis, 19, pp. i1327 - i1328, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0852

Pudipeddi A; Lin H; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An YK; Begun J; Connor S; Corte C; Ward M; De Cruz P; Fung C; Redmond D; Chan W; Mourad F; Kermeen M; Leong R, 2025, 'P0754 Extensive disease clearance as a novel composite endpoint to predict long-term relapse in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial', Journal of Crohn's and Colitis, 19, pp. i1453 - i1454, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0928

Cosier D; Lambert K; Karen C; Batterham M; Little RD; Wu N; Tavakoli P; Ghaly S; Pipicella JL; Connor S; Leach S; Lemberg D; Houshyar Y; Jayawardana T; Koentgen S; Hold G, 2025, 'P0759 The interplay between dietary intake and disease activity in Australian adults with and without Inflammatory Bowel Disease', Journal of Crohn's and Colitis, 19, pp. i1465 - i1465, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0933

Pinnuck B; Su WK; Wilson W; Pipicella J; Wark G; Archdiacono M; Walker G; Forbes A; Su H; Schultz M; Lawrance I; Dutt S; Brett L; Lynch K; Connor SJ; Andrews JM, 2025, 'P0938 Corticosteroid and opiate use in Inflammatory Bowel Disease, 25 years after the Crohn’s Therapy, Resource, Evaluation, and Assessment Tool (TREAT) registry was established', Journal of Crohn's and Colitis, 19, pp. i1759 - i1759, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1112

Cameron K; Sam M; Theena N; Gu B; Arzivian A; Skinner T; Shelton E; Connor SJ; Toong C; Gibson PR; Gibson DJ; Sparrow MP; Ward MG, 2025, 'P0967 The role of bound anti-drug antibodies to infliximab in predicting future immunogenic failure when de-escalating from combination therapy with an immunomodulator to anti-TNF monotherapy (RAPID-IM Study)', JOURNAL OF CROHNS & COLITIS, 19, pp. i1799 - i1799, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1141

Rivas C; Su WK; Wilson W; Ng W; Ghaly S; Walker G; Forbes A; Su H; Schultz M; Lawrance I; Dutt S; Brett L; Begun J; Lynch K; Andrews JM; Connor S, 2025, 'P1132 Patterns and predictors of steroid use in people with IBD in routine care across ANZ', Journal of Crohn's and Colitis, 19, pp. i2073 - i2073, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1306

Seng C; Su WK; Wilson W; Connor SJ; Andrews JM; Walker G, 2025, 'P1225 A cross-sectional study of Inflammatory Bowel Disease in older people across Australasia, a Crohn’s Colitis Cure data insights program', Journal of Crohn's and Colitis, 19, pp. i2216 - i2217, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1399

Jayawardana T; Little RD; Zhang F; Koentgen S; Wu N; Tavakoli P; Sidhu S; Le A; Boussioutas A; Ward MG; P SM; Gibson PR; Ghaly S; Corte C; Talley NJ; Leach S; Lemberg D; Dutt S; Paramsothy S; Leong R; Connor SJ; Hold G; Study AIM, 2025, 'P1327 Microbial signatures associated with Inflammatory Bowel Disease in Australia: baseline data from the Australian IBD Microbiome study', Journal of Crohn's and Colitis, 19, pp. i2388 - i2389, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1501

Little R; Jayawardana T; Zhang F; Koentgen S; Wu N; Tavakoli P; Chung A; Ho A; Read S; Boussioutas A; Ward M; Sparrow M; Gibson P; Ghaly S; Corte C; Talley N; Leach S; Lemberg D; Dutt S; Paramsothy S; Leong R; Connor S; Hold G, 2025, 'P1340 Gut microbiota changes are associated with type of advanced therapy in patients with Inflammatory Bowel Disease: baseline data from the Australian IBD Microbiome study', Journal of Crohn's and Colitis, 19, pp. i2410 - i2412, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1514

Jayawardana T; Little RD; Zhang F; Koentgen S; Wu N; Houshyar Y; Tavakoli P; Boussioutas A; Ward MG; Sparrow MP; Gibson PR; Ghaly S; Corte C; Talley NJ; Leach S; Lemberg D; Dutt S; Paramsothy S; Leong R; Connor SJ; Hold G; Study AIM, 2025, 'P1344 Impaired health-related quality of life is associated with alterations in gut microbiota signatures in patients with Inflammatory Bowel Disease: baseline data from the Australian IBD Microbiome study', Journal of Crohn's and Colitis, 19, pp. i2419 - i2421, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1518

Little R; Jayawardana T; Zhang F; Houshyar Y; Koentgen S; Wu N; Ellepola A; Tavakoli P; Chung A; Ho A; Read S; Boussioutas A; Ward M; Sparrow M; Gibson P; Ghaly S; Corte C; Talley N; Leach S; Lemberg D; Dutt S; Paramsothy S; Leong R; Connor S; Hold G, 2025, 'P1345 Association of gut microbiota changes and disease activity in patients with Crohn’s disease and ulcerative colitis: baseline data from the Australian IBD Microbiome study', Journal of Crohn's and Colitis, 19, pp. i2422 - i2423, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1519

De Gregorio M; Winata LS; Behrenbruch CC; Hartley I; Connor SJ; D'Souza B; Johnston MJ; Kamm MA; Keck JO; Rimola J; Sutherland T; Woods RJ; Wright EK; Connell WR; Thompson AJ; Ding NS, 2025, 'Scoring indices grading radiologic disease activity severity on magnetic resonance imaging strongly reflect clinical healing of Crohn's perianal fistulas', JOURNAL OF CROHNS & COLITIS, 19, pp. I693 - I693, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0434

Van Oostrom J; Anjie S; Lasa J; Karimi N; Horrigan J; Sareen H; Adi B; Ganesh G; Parks ML; Broer C; de Kruif A; Peyrin-Biroulet L; Ye BD; Banerjee R; Olivera P; Siegel C; Connor S; Gecse K; D'Haens G; IBD LC, 2025, 'World-wide Development and Validation of the IBD LIFE Questionnaire and Country-specific Patterns of Normal Life Impairment', JOURNAL OF CROHNS & COLITIS, 19, pp. i965 - i966, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0624

De Gregorio M; Winata LS; Hartley I; Behrenbruch CC; Connor SJ; D‘Souza B; Basnayake C; Guerra GR; Johnston MJ; Kamm MA; Keck JO; Lust M; Niewiadomski O; Ong EJS; Schulberg JD; Srinivasan A; Sutherland T; Woods RJ; Wright EK; Connell WR; Thompson AJ; Ding NS, 2025, 'A new protocolized treatment strategy optimizing medical and surgical care leads to improved healing of Crohn’s perianal fistulas', Journal of Crohn S and Colitis, 19, http://dx.doi.org/10.1093/ecco-jcc/jjae199

McNamara J; Wilson W; Pipicella JL; Ghaly S; Begun J; Lawrance IC; Gearry R; Andrews JM; Connor SJ, 2025, 'Epidemiology and Treatment Patterns of Fistulizing Crohn's Disease in a Large, Real-World Australasian Cohort', Gastro Hep Advances, 4, http://dx.doi.org/10.1016/j.gastha.2024.100594

Karimi N; Moore AR; Jones A; Lukin A; Pipicella JL; Williams AJ; Ng W; Kanazaki R; Kariyawasam V; Mitrev N; Pandya K; Andrews JM; Connor SJ, 2025, 'On being on the same page: Predictors of gastroenterologist-patient misalignment in inflammatory bowel disease', Patient Education and Counseling, 130, http://dx.doi.org/10.1016/j.pec.2024.108487

Akyüz F; An YK; Begun J; Aniwan S; Bui HH; Chan W; Choi CH; Chopdat N; Connor SJ; Desai D; Flanagan E; Kobayashi T; Lai AYH; Leong RW; Leow AHR; Leung WK; Limsrivilai J; Muzellina VN; Peddi K; Ran Z; Wei SC; Sollano J; Teo MMH; Wu K; Ye BD; Ooi CJ, 2025, 'Optimizing 5-aminosalicylate for moderate ulcerative colitis: expert recommendations from the Asia-Pacific, Middle East, and Africa Inflammatory Bowel Disease Coalition', Intestinal Research, 23, pp. 37 - 55, http://dx.doi.org/10.5217/ir.2024.00089

Hanna LN; Munster LJ; Joshi S; van der Bilt JDW; Buskens CJ; Hart A; Tozer P; Collaborators T; Adam J; Anand E; Anandabaskaran S; Ballard DH; Behrenbruch C; Bislenghi G; Bonifacio C; Carvello M; Catalán-Serra I; Cohen BL; Colombel J-F; Connor SJ; D’Hoore A; De Kock I; De Looze D; de Parades V; Deepak P; Dige A; Ding NS; Ouali SE; Fathallah N; Geldof J; Holubar SD; Kotze PG; LeBlanc J-F; Lightner AL; Lundby L; Lung PFC; Martinez A; McCurdy JD; McDonald BD; McGovern DPB; Moran GW; Pelly T; Polydorides AD; Powell N; Queiroz NSF; Rubin DT; Sahnan K; Sebastian S; Spinelli A; Stoker J; Vermeire S; Verstockt B; Warusavitarne J; Winata LS; Wong S-Y, 2025, 'Isolated perianal Crohn's disease: a systematic review and expert consensus proposing novel diagnostic criteria and management advice', The Lancet Gastroenterology & Hepatology, 10, pp. 757 - 768, http://dx.doi.org/10.1016/s2468-1253(25)00007-x

Pinnuck BC; Su WK; Wilson WE; Pipicella JL; Ng W; Antoniades SA; Walker G; Forbes AJ; Dutt S; Lynch KD; Connor SJ; Andrews J, 2025, 'Mo1891: IRON DEFICIENCY, WITH OR WITHOUT ANAEMIA, IN INFLAMMATORY BOWEL DISEASE REMAINS AN UNDERMANAGED ISSUE: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM', Gastroenterology, 169, pp. s-1210-s-1211, http://dx.doi.org/10.1016/s0016-5085(25)03678-9

Su WK; McNamara J; Wilson WE; Wark G; Lynch KD; Su HY; Forbes AJ; Lawrance IC; An Y-K; Dutt S; Brett L; Walker G; Andrews JM; Connor SJ; Ghaly S, 2025, 'Mo1954: CONSISTENCY AND QUALITY OF INFLAMMATORY BOWEL DISEASE CARE IN AUSTRALASIA; TOWARDS BENCHMARKING.', Gastroenterology, 169, pp. s - 1240, http://dx.doi.org/10.1016/s0016-5085(25)03741-2

Jayawardana TC; Little RD; Zhang F; Koentgen S; Wu N; Houshyar Y; Tavakoli P; Boussioutas A; Ward M; Sparrow M; Gibson PR; Ghaly S; Corte C; Talley NJ; Leach ST; Lemberg DA; Dutt S; Paramsothy S; Leong RW; Connor SJ; Hold GL, 2025, 'Mo1960: IMPAIRED HEALTH-RELATED QUALITY OF LIFE IS ASSOCIATED WITH ALTERATIONS IN GUT MICROBIOTA SIGNATURES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: BASELINE DATA FROM THE AUSTRALIAN IBD MICROBIOME STUDY.', Gastroenterology, 169, pp. s - 1243, http://dx.doi.org/10.1016/s0016-5085(25)03747-3

Oostrom J; Anjie SI; Lasa JS; Karimi N; Horrigan J; Sareen H; Adi B; Ganesh G; Yang S-K; Parks L; Broër C; de Kruif A; Peyrin-Biroulet L; Ye BD; Banerjee R; Sendra PO; Siegel CA; Connor SJ; Gecse K; D’Haens G, 2025, 'Mo1964: THE IBD LIFE QUESTIONNAIRE: WORLD-WIDE DEVELOPMENT AND VALIDATION AND INTERCONTINENTAL DIFFERENCES OF NORMAL LIFE IMPAIRMENT', Gastroenterology, 169, http://dx.doi.org/10.1016/s0016-5085(25)03751-5

Gu B; Su WK; Nano D; Wilson WE; Iliescu S; Lynch KD; Andrews JM; Connor SJ; Ghaly S, 2025, 'Mo1974: ACTIVE PERIANAL FISTULISING CROHN’S DISEASE IS ASSOCIATED WITH A HIGHER BURDEN OF PSYCHOLOGICAL DISTRESS, DEPRESSION, ANXIETY, STRESS AND OPIOID USE', Gastroenterology, 169, pp. S - 1251, http://dx.doi.org/10.1016/s0016-5085(25)03761-8

Little RD; Jayawardana TC; Zhang F; Koentgen S; Wu N; Tavakoli P; Chung A; Ho A; Read S; Boussioutas A; Ward M; Sparrow M; Gibson PR; Ghaly S; Corte C; Talley NJ; Leach ST; Lemberg DA; Dutt S; Paramsothy S; Leong R; Connor SJ; Hold GL, 2025, 'Sa1795: GUT MICROBIOTA CHANGES ARE ASSOCIATED WITH TYPE OF ADVANCED THERAPY IN PATIENTS WITH IBD: BASELINE DATA FROM THE AUSTRALIAN IBD MICROBIOME STUDY', Gastroenterology, 169, pp. s - 532, http://dx.doi.org/10.1016/s0016-5085(25)02163-8

Pinnuck BC; Su WK; Wilson WE; Pipicella JL; Wark G; arcidiacono M; Walker G; Forbes AJ; Su H; Schultz M; Lawrance IC; Dutt S; Brett L; Lynch KD; Connor SJ; Andrews J, 2025, 'Sa1917: CORTICOSTERIOD AND OPIATE USE IN INFLAMMATORY BOWEL DISEASE, 25 YEARS AFTER THE CROHN’S THERAPY, RESOURCE, EVALUATION, AND ASSESSMENT TOOL (TREAT) WAS ESTABLISHED', Gastroenterology, 169, pp. s - 583, http://dx.doi.org/10.1016/s0016-5085(25)02279-6

Pudipeddi A; Paramsothy S; Kariyawasam VC; Paramsothy R; Ghaly S; Haifer C; An Y-K; Begun J; Connor SJ; Corte C; Ward M; De Cruz P; Fung CL; Redmond D; Chan PW; Mourad FH; Kermeen M; Leong R, 2025, 'Su1899: EXTENSIVE DISEASE CLEARANCE AS A NOVEL COMPOSITE ENDPOINT TO PREDICT LONG-TERM RELAPSE IN VEDOLIZUMAB-TREATED PATIENTS WITH ULCERATIVE COLITIS: A POST-HOC ANALYSIS FROM THE VIEWS RANDOMISED CONTROLLED TRIAL', Gastroenterology, 169, pp. S - 879, http://dx.doi.org/10.1016/s0016-5085(25)02960-9

Pudipeddi A; Paramsothy S; Kariyawasam VC; Paramsothy R; Ghaly S; Haifer C; An Y-K; Begun J; Connor SJ; Corte C; Ward M; De Cruz P; Fung CL; Redmond D; Chan PW; Mourad FH; Kermeen M; Leong R, 2025, 'Su1943: CORRELATION OF BIOCHEMICAL, ENDOSCOPIC AND HISTOLOGIC ENDPOINTS IN VEDOLIZUMAB-TREATED PATIENTS WITH ULCERATIVE COLITIS: A POST-HOC ANALYSIS FROM THE VIEWS RANDOMISED CONTROLLED TRIAL', Gastroenterology, 169, pp. S - 900, http://dx.doi.org/10.1016/s0016-5085(25)03004-5

Rivas C; Su WK; Wilson WE; Ng W; Ghaly S; Walker G; Forbes AJ; Su H; Schultz M; Lawrance IC; Dutt S; Brett L; Begun J; Lynch KD; Andrews JM; Connor SJ, 2025, 'Tu1094: PATTERNS AND PREDICTORS OF STEROID USE IN PEOPLE WITH IBD IN ROUTINE CARE ACROSS ANZ', Gastroenterology, 169, pp. s-1305-s-1306, http://dx.doi.org/10.1016/s0016-5085(25)03886-7

Cosier D; Lambert K; Charlton K; Batterham M; Little RD; Wu N; Tavakoli P; Ghaly S; Pipicella JL; Connor S; Leach S; Lemberg DA; Houshyar Y; Jayawardana T; Koentgen S; Hold GL, 2024, 'Dietary Patterns and Fibre Intake Are Associated with Disease Activity in Australian Adults with Inflammatory Bowel Disease: An Exploratory Dietary Pattern Analysis †', Nutrients, 16, http://dx.doi.org/10.3390/nu16244349

Kanazaki R; Smith B; Bu S; Girgis A; Connor SJ, 2024, 'Is the European Crohn’s and Colitis organisation (ECCO) e-guide an acceptable and feasible tool for increasing gastroenterologists’ guideline adherence? A mixed methods evaluation', BMC Medical Education, 24, http://dx.doi.org/10.1186/s12909-024-05540-w

Jacob R; Chu V; Ng W; Williams AJ; Connor S, 2024, 'Treatment outcomes of mild to moderate Clostridioides difficile infection in inflammatory bowel disease: an Australian experience', Internal Medicine Journal, 54, pp. 2009 - 2014, http://dx.doi.org/10.1111/imj.16545

Pierre N; Huynh-Thu VA; Baiwir D; Mazzucchelli G; Fléron M; Trzpiot L; Eppe G; De Pauw E; Laharie D; Satsangi J; Bossuyt P; Vuitton L; Vieujean S; Colombel JF; Meuwis MA; Louis E; Dupas JL; Reimund JM; Bouhnik Y; Jouet P; De Vos M; Belaiche J; Vernier-Massouille G; Nancey S; Grimaud JC; Veyrac M; Boureille A; Flamant M; Jian R; Marteau P; Lemann M; Allez M; Savoye G; Duclos B; Picon L; Andrews A; Sparrow M; Leong R; Connor S; Radforth-Smith G; De Cruz P; Baert F; Louis E; Bossuyt P; Resche-Rignon M; Ding N; Almer S; Ben-Horin S; Siegmund B; Preiss J; Stallmach A; Liceni T; Grip O; Halfvarson J; Durai D; Cummings F; Seilinger C; Parkes M; Lindsay J; Lambrecht G; VanHootegem P; Rahier JF; Dewitte M; Hebuterne X; Chanteloup E; Altwegg R; Bouguen G; de Chambrun GP; Pollenot F; Nachury M; Fumery M; Gilletta C; Viennot S; Roblin X; Irving P; Lamb C; Pollok R; D'Haens G; Hertervig E; Halfvarsson J, 2024, 'External validation of serum biomarkers predicting short-term and mid/long-term relapse in patients with Crohn's disease stopping infliximab', Gut, 73, pp. 1965 - 1973, http://dx.doi.org/10.1136/gutjnl-2024-332648

Pudipeddi A; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An YK; Begun J; Connor SJ; Corte C; Ward MG; De Cruz P; Lan-San Fung C; Redmond D; Chan W; Mourad F; Kermeen M; Leong RW, 2024, 'Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: A Randomized Controlled Trial', Clinical Gastroenterology and Hepatology, 22, pp. 2299 - 2308.e5, http://dx.doi.org/10.1016/j.cgh.2024.04.019

Katsoudas N; Tavakoli P; Wu N; Shapiro A; Leach ST; Williams AJ; Paramsothy R; Ghaly S; Connor SJ; Samocha-Bonet D; Lambert K; Hold GL, 2024, 'Dietary Emulsifier Exposure in People with Inflammatory Bowel Disease Compared with Healthy Controls: Is There a Cause for Concern?', Inflammatory Bowel Diseases, 30, pp. 1241 - 1250, http://dx.doi.org/10.1093/ibd/izad318

Little RD; McKenzie J; Srinivasan A; Hilley P; Gilmore RB; Chee D; Sandhu M; Saitta D; Chow E; Thin L; Walker GJ; Moore GT; Lynch K; Andrews J; An YK; Bryant RV; Connor SJ; Garg M; Wright EK; Hold G; Segal JP; Boussioutas A; De Cruz P; Ward MG; Sparrow MP, 2024, 'Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trial', BMJ Open, 14, http://dx.doi.org/10.1136/bmjopen-2023-081787

De Gregorio M; Sidhu A; Behrenbruch C; Connor SJ; Guerra G; Johnston MJ; Keck JO; Ong EJSK; Thompson AJ; Woods R; D'Souza B; Ding NS, 2024, 'Preferred definitive surgical management of Crohn's perianal fistulas and factors influencing surgical decision making in Australia and New Zealand', ANZ Journal of Surgery, 94, pp. 14 - 16, http://dx.doi.org/10.1111/ans.18640

Alshiwanna B; Mcnamara J; Wilson W; Pipicella JL; Ghaly S; Gearry R; Begun J; Williams A; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Connor SJ; Andrews JM, 2024, 'P1005 Dose escalated Infliximab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i1809 - i1809, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1135

Barnett M; Mcnamara J; Wilson W; Pipicella J; Ghaly S; Gearry R; Begun J; Williams A; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Connor SJ; Andrews JM, 2024, 'P1012 Dose escalated Ustekinumab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i1820 - i1820, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1142

Back to profile page